Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 ISIN · KYG1609T1022 HKEX Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2023-08-29 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023' and contains detailed unaudited consolidated interim financial statements including profit or loss, comprehensive income, financial position, and notes to the interim condensed consolidated financial information. It covers the six-month period ending June 30, 2023, which is a period shorter than a full fiscal year. The document includes substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-29 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Broncus Holding Corporation regarding the date of a board meeting to consider and approve the unaudited interim results for the six months ended June 30, 2023. It does not contain the actual interim financial results or substantive financial data but merely announces the upcoming board meeting and the intention to publish the interim results. The document length is short (1395 characters) and fits the pattern of a notice rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not contain the full report or detailed financial data.
2023-08-17 English
INSIDE INFORMATION TERMINATION OF CONCERT PARTY AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement from Broncus Holding Corporation regarding the termination of a Concert Party Agreement between shareholders QM12 and BBL. It references the Listing Rules of the Hong Kong Stock Exchange and the Securities and Futures Ordinance, indicating it is a regulatory announcement. The content focuses on shareholder agreements and changes in concert party status, which relates to shareholder groupings and control but does not report financial results, management changes, or capital structure changes. The document is relatively short (4183 characters) and serves as an official announcement rather than a detailed report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not about board or management changes, nor is it a voting result or dividend notice. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on authorized and issued shares, share options, and confirmations related to share capital for Broncus Holding Corporation. It includes data on share capital, share options, and confirmations by a director. The document is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not a full annual or interim financial report, nor is it an earnings release or management discussion. It is a regulatory filing related to share capital movements and confirmations, fitting the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a direct announcement of a new share issue or capital change event. The document length and content confirm it is a substantive regulatory filing rather than a brief announcement or certification only.
2023-08-04 English
VOLUNTARY ANNOUNCEMENT BRONCUS COMPLETES THE FIRST CASE OF REGISTERED CLINICAL TRIALS OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Broncus Holding Corporation regarding the completion of the first case of registered clinical trials for its targeted lung denervation radiofrequency ablation system. It provides business development updates and clinical trial progress but does not contain financial statements, detailed financial analysis, or regulatory filings. The document is relatively short (5179 characters) and serves as a business update rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is not related to board changes, voting results, or capital changes. The content is a voluntary business update announcement about clinical trial progress and product development, which is best classified under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-07-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on authorized and issued share capital, share options, and confirmations related to securities issued by Broncus Holding Corporation. It includes data on share capital, share options, and confirmations by a director. The document is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not an annual or quarterly financial report, nor is it an earnings release or management discussion. It is not a proxy statement, voting results, or a merger announcement. The content is focused on share capital movements and share option schemes, which aligns with announcements regarding share issues or capital changes. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (8844 characters) and detailed data support it being a substantive report rather than a brief announcement or certification.
2023-07-06 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.